1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Eversource Energy said it completed the sale of Aquarion Water Company to Aquarion Water Authority, a Connecticut public entity, for $2.4 billion in cash. The company expects an after-tax non-cash charge of about $115 million, or $0.31 per share, in the second quarter of 2026, and it revised its 2026 non-GAAP EPS guidance to $4.57 to $4.72 per share, which excludes Aquarion earnings going forward.
Total purchase price was $2.4 billion in cash; adjusted net equity proceeds of about $1.7 billion will be used to pay down Eversource debt.
After-tax non-cash charge of about $115 million, or $0.31 per share, expected in Q2 2026.
Revised 2026 non-GAAP guidance is $4.57 to $4.72 per share; the prior base-year midpoint cited is $4.65 per share.
Sale was approved by the Connecticut Public Utilities Regulatory Authority on March 25, 2026, after a definitive agreement signed January 27, 2025.
Patrick Industries agreed to acquire LCI Industries in an all-stock merger in which LCI shareholders receive 1.2440 Patrick shares for each LCI share. After closing, Patrick holders would own about 52% of the combined company and LCI holders about 48%, and the company is expected to close in the first half of 2027, subject to shareholder and regulatory approvals.
Exchange ratio: 1.2440 Patrick common shares for each LCI common share, plus cash in lieu of fractional shares
Ownership after closing: about 52% Patrick shareholders and 48% LCI shareholders
Companies cite more than $150 million of estimated run-rate cost synergies, to be achieved within three years of closing
Outside Date for the Mergers is March 30, 2027, with two three-month extensions possible for regulatory conditions; Andy Nemeth remains CEO and Todd Cleveland is named Chair
Advanced Biomed Inc. agreed on June 30, 2026 to sell 100% of Advanced Biomed Inc. (Taiwan), its wholly-owned subsidiary that runs its biomedical research and development, to an unrelated third party. The filing says the company will keep its remaining businesses, including AI-focused operations through Acellent Technologies (Hong Kong) Co. Limited, and the closing is expected within three months.
Aggregate purchase price is US$490,000, subject to the agreement's terms and conditions.
The Taiwan Subsidiary conducts the company's biomedical R&D, including the A+PerfusC 3D cell culture platform.
Closing is expected within three months of the agreement date; the filing lists closing conditions as a risk factor.
The full Share Purchase Agreement is filed as Exhibit 10.1.
Spire Inc. completed the sale of its Spire Storage businesses, which hold natural gas storage assets in Wyoming and Oklahoma, to an affiliate of I Squared Capital on June 30, 2026. The 8-K gives total consideration of $657 million, while the accompanying press release states $650 million, so the figures differ slightly. Spire says the proceeds will support its regulated utility operations, capital plan and debt reduction, and help fund its earlier Piedmont Natural Gas Tennessee acquisition.
Total consideration is $657 million in the 8-K: $607 million cash at closing, subject to price adjustments, plus $50 million deferred until September 30, 2027.
The press release states $650 million total ($600 million cash at closing plus a $50 million deferred payment in fiscal 2027).
Proceeds help fund the Piedmont Natural Gas Tennessee acquisition, which closed March 31, 2026.
The storage business will operate as Bear River Midstream LLC under I Squared; the Wyoming assets can provide up to 55 Bcf of working gas capacity and the Oklahoma facility up to 17 Bcf.
Talos Energy and an affiliate of Ridgewood Energy agreed on June 30, 2026 to buy oil and gas properties in the Gulf of America from Shell Offshore for an unadjusted $1.7 billion, with Talos's share at $850 million. Talos expects its final net cash consideration to be about $450 million to $500 million, and it plans to fund the deal with cash on hand and debt, which shareholders should weigh against the added production and reserves and the closing uncertainty.
Talos's share of the unadjusted purchase price is $850 million, with a $42.5 million deposit already in escrow and credited at closing.
Acquired assets include about 23 MMBoe of proved reserves, 10 MMBoe of probable reserves, and first quarter 2026 average production of about 16 MBoe/d (about 77% oil).
BP has a 30-day preferential right on the Na Kika interests; if exercised, Talos would acquire only the Coulomb field interest.
The credit agreement amendment raises the borrowing base from $700 million to $850 million ($800 million if BP exercises its right), effective upon closing, and the deal is expected to close by the end of 2026.
ZW Data Action Technologies said its subsidiary CNET Technology Limited signed a June 26, 2026 agreement to buy an 8.0% equity interest in Margo Asia Limited from Affirm Mission Limited. The purchase price is $474,000 in cash plus 180,000 company common shares valued at $126,000, and closing is subject to customary conditions. The filing is a small acquisition with modest cash and share cost relative to the company's size, as the filing gives no financial data for the company or Margo.
Agreement dated June 26, 2026, between subsidiary CNET Technology Limited, Affirm Mission Limited and Margo Asia Limited
Cash consideration of $474,000 plus 180,000 common shares valued at $126,000, or $0.70 per share
Closing is subject to customary terms and conditions set out in the agreement, included as Exhibit 10.1
LCI Industries and Patrick Industries signed a merger agreement on June 30, 2026 under which LCI would become a wholly owned subsidiary of Patrick, and LCI shareholders would receive 1.2440 Patrick shares for each LCI share. After closing, Patrick holders would own about 52% of the combined company and LCI holders about 48%, and the deal is expected to close in the first half of 2027, subject to shareholder, regulatory and other conditions.
Exchange ratio: 1.2440 shares of Patrick common stock for each LCI common share, plus cash in lieu of fractional shares
Ownership after closing: Patrick shareholders about 52%, LCI shareholders about 48%
The companies estimate more than $150 million of run-rate cost synergies, achieved within three years of closing
Outside Date for completion is March 30, 2027; expected closing is the first half of 2027
Pacira agreed on June 28, 2026 to sell its iovera handheld cryoanalgesia device business, including subsidiary Pacira CryoTech, to Zimmer, a subsidiary of Zimmer Biomet, for up to $140 million. The deal includes a $70 million upfront payment and up to $70 million in revenue-based milestone payments through December 31, 2031, and is expected to close in the third quarter of 2026. The company says it intends to use the upfront proceeds to strengthen its balance sheet, including paying down its senior secured revolving credit facility.
Upfront payment of $70.0 million, subject to customary adjustments for cash, receivables, indebtedness, transaction expenses and inventory
Milestone payments of $18.5 million, $23.5 million and $28.0 million if annual iovera net revenue reaches $50 million, $60 million or $70 million in any period from 2027 through 2031
66 employees expected to join Zimmer, about 8% of Pacira's total workforce
Purchase Agreement signed June 28, 2026; transaction expected to close in the third quarter of 2026
Angel Studios amended and restated its merger agreements to acquire Tuttle Twins Show, LLC (TTS) and Toothy Cow Productions, LLC (TCP), both signed November 14, 2025. The changes extend the outside date to October 31, 2026, and alter several closing conditions and the TCP merger structure. Company insiders and affiliates hold units in both companies and would receive Class A shares in the deals, and the company has already provided funding to both.
Outside date for both the TTS and TCP mergers extended to October 31, 2026
Closing condition requiring a showrunner agreement for Daniel Harmon removed from the TTS deal
Company related parties own 41.6% of TTS units and 2.4% of TCP units as of June 23, 2026
Company has provided $11.7 million to TTS and $11.9 million to TCP to date, with a maximum TCP funding commitment of $11.9 million
General Fusion and Spring Valley Acquisition Corp. III filed an updated investor presentation under Regulation FD, replacing the version furnished on April 29, 2026. The presentation covers the proposed business combination, which the SEC declared effective on June 12, 2026, and the related proxy materials mailed to Spring Valley shareholders on June 15, 2026.
Updated presentation (Exhibit 99.1) supersedes the version filed with the SEC on April 29, 2026
SEC declared the Form F-4 registration statement effective on June 12, 2026
Proxy statement mailed June 15, 2026 to Spring Valley shareholders of record as of June 12, 2026
Presentation cites a $600 million General Fusion pre-money valuation and a $108 million PIPE priced at $12.00 per share
On June 27, 2026, Martin Marietta agreed to acquire all equity interests in Lhoist North America from LNA Holding for $13.5 billion, consisting of $7 billion in cash and 10,953,543 newly issued Martin Marietta shares valued at $6.5 billion. After closing, LNA Holding is expected to hold about 15% of Martin Marietta's common stock, and the company has a $7.0 billion bridge loan commitment to fund the cash portion, so shareholders would face a larger share count and significant new borrowing if the deal closes.
Total consideration is $13.5 billion: $7 billion in cash plus 10,953,543 shares valued at $6.5 billion, based on the 15-day volume-weighted average price ending June 26, 2026
Closing requires expiration or termination of the Hart-Scott-Rodino waiting period and other regulatory approvals; long stop date is October 31, 2026, extendable to June 15, 2027
Martin Marietta would pay a $350 million termination fee if the deal ends under specified circumstances tied to failure to obtain regulatory clearances by the Extended Long Stop Date
A 364-day, $7.0 billion unsecured bridge facility from Goldman Sachs Bank USA and Goldman Sachs Lending Partners LLC is committed to finance the cash consideration
SandRidge Energy's subsidiary signed a purchase agreement on June 26, 2026, to acquire oil and gas properties in the Cherokee Play from Rockies Resources Holdings LLC for $65 million in cash, plus three contingent earn-out payments of $2 million each. The company expects to fund the deal with cash on hand and close it in the third quarter of 2026, subject to customary closing conditions. The filing does not report financial results from the assets, so shareholders have no figures yet on how the deal will affect revenue or earnings.
Cash consideration of $65 million at closing, subject to customary purchase price adjustments
Three contingent earn-out payments of $2 million each, tied to WTI crude oil price thresholds from July 1, 2026 through December 31, 2027
Acquired assets include net production of about 3.0 MBoed (about 43% oil), about 7,000 net leasehold acres, interests in 21 wells and eight proven development locations
Expected closing in the third quarter of 2026; the press release says the effective date is May 1, 2026
JATT II Acquisition Corp., a blank check company, entered a business combination agreement with Talawar Tx Inc., a biotechnology developer of bispecific antibodies. The combined company is expected to trade on Nasdaq as TLWR and to receive up to $285 million before transaction costs, including a $225 million PIPE financing at $10.00 per share, if there are no redemptions by JATT II shareholders.
Business combination agreement signed June 29, 2026; JATT II shareholders must approve the deal, and closing is expected in the second half of 2026
Expected proceeds of $285 million before transaction costs, assuming no redemptions: $60 million from the JATT II trust account plus a $225 million PIPE
Combined company expected to trade on Nasdaq Capital Market under ticker TLWR; lead asset TALA-125 targets clinic entry in Q1 2027
Rocket Lab agreed on June 28, 2026 to acquire Iridium Communications in a cash and stock deal valued at $54 per Iridium share and an enterprise value of about $8.0 billion. Iridium holders would receive $27.00 in cash plus Rocket Lab stock, with the stock portion set by an exchange ratio that is subject to a collar between $67.50 and $112.50 per Rocket Lab share. The deal requires Iridium shareholder approval and regulatory clearances and is expected to close in mid-2027, and it is funded partly by a $3.6 billion bridge loan commitment.
Iridium holders receive $27.00 in cash plus Rocket Lab shares at an exchange ratio that is fixed at 0.4000 if the Rocket Lab price is $67.50 or below and at 0.2400 if it is $112.50 or above.
Iridium would pay Rocket Lab a $223.62 million termination fee in specified circumstances, including if its board withdraws support for the deal.
Rocket Lab has a 364-day senior secured bridge term loan commitment of $3.6 billion from Deutsche Bank and Wells Fargo.
The transaction is expected to close in mid-2027 and must be approved by a majority of Iridium's outstanding shares.
On June 28, 2026, Iridium agreed to merge with Rocket Lab, which will acquire all outstanding Iridium common stock for $27.00 in cash plus Rocket Lab shares per Iridium share. The companies put the notional value at $54.00 per share and the enterprise value at approximately $8.0 billion, and the deal requires an Iridium stockholder vote, antitrust clearance, and FCC consent. Iridium would owe Rocket Lab a $223.62 million termination fee in specified circumstances, and its shares would be delisted from Nasdaq if the deal closes.
Each Iridium share receives $27.00 in cash plus Rocket Lab stock; the exchange ratio is fixed at 0.4000 if the Rocket Lab price is $67.50 or less and at 0.2400 if it is $112.50 or more.
The transaction is expected to close in mid-2027, with an outside date of June 28, 2027, extendable to December 28, 2027.
Iridium would pay Rocket Lab a $223.62 million termination fee under specified circumstances, including if its board withdraws its recommendation.
Rocket Lab has received commitments for a $3.6 billion 364-day senior secured bridge term loan from Deutsche Bank and Wells Fargo.
Verizon signed a transaction agreement on June 28, 2026 with BT Group and NewCo to combine its international wireline connectivity and managed network services business with BT's equivalent business, with each company holding 50% of NewCo. Verizon will also make a $625 million cash payment to NewCo, which will pass it to BT, and it expects a second-quarter 2026 estimated loss of $700 million to $800 million, plus severance and asset charges, that will weigh on reported results.
Transaction agreement signed June 28, 2026; closing is subject to customary regulatory approvals and closing conditions.
Verizon to pay $625 million in cash to NewCo; the value of each contributed business is subject to adjustment for cash, net working capital and indebtedness at closing.
Expected second-quarter 2026 estimated loss of $700 million to $800 million from classifying the Verizon Contributed Business as held for sale.
Severance charge of $350 million to $450 million and asset rationalization charges of $200 million to $300 million expected in the second quarter of 2026.
On June 27, 2026, Korn Ferry agreed to acquire AMS, a talent and consulting firm, for about £850 million (about $1.1 billion), with about $881 million in cash and about $255 million in Korn Ferry common stock. Closing requires regulatory approvals and is expected in the fiscal quarter ending October 30, 2026. Shareholders will see new shares issued and cash funded partly by revolver borrowings, and the company expects the deal to be immediately accretive to earnings per share in the first full year after adjusting for restructuring, integration and transaction costs.
Total price is about £850 million (about $1.1 billion): about $881 million in cash and about $255 million in Korn Ferry shares.
Cash funding is about $300 million from cash on hand and about $581 million from borrowings under the existing revolver.
AMS has about $650 million of run-rate fee revenue and $100 million of Adjusted EBITDA, according to the press release.
Closing requires HSR waiting period expiry and UK and German approvals, and may be terminated if conditions are not met within 180 days of signing.
Bristow Group agreed on June 23, 2026 to buy Berry Aviation, a special missions and government aviation provider, for $105 million in cash, subject to adjustments. The company also said it is pursuing a sale of its Norway offshore energy services business, and that the Berry deal would be neutral to its 2025 EBITDA on a pro forma basis with that exit.
Purchase price is $105 million in cash, subject to adjustment for working capital, cash, indebtedness and transaction expenses
Berry Aviation had 2025 total revenues of approximately $108 million and 2025 EBITDA of approximately $12 million, per the investor slides
Closing is expected in the third quarter of 2026 per the press release; the 8-K says the second half of 2026
Bristow intends to fund the deal with cash on hand; the Norway sale timing and structure remain subject to market conditions
H.B. Fuller and the board of Advanced Medical Solutions Group plc (AMS) agreed terms on a recommended cash offer, to be implemented through a UK court-sanctioned scheme of arrangement. The company has arranged bridge credit agreements of up to $2,086,713,188 (secured) and $917,000,000 (unsecured) to fund the deal and refinance debt, and expects completion by the end of calendar 2026, which would add new borrowings for shareholders to weigh against the strategic growth case.
AMS shareholders will receive 285 pence in cash per AMS share; the press release cites a total enterprise value of £715 million.
Secured Bridge Credit Agreement of up to $2,086,713,188 and Unsecured Bridge Credit Agreement of up to $917,000,000, both with Goldman Sachs Bank USA; loans would mature 364 days after closing.
Completion is expected by the end of calendar 2026, subject to AMS shareholder approval, High Court sanction, regulatory approvals, and a Long-Stop Date of June 25, 2027.
Company expects approximately $55 million in combined run-rate revenue and cost synergies by 2031.
Bio-Techne entered a merger agreement under which Merck KGaA's subsidiary will merge into the company, leaving Bio-Techne as a wholly-owned Merck KGaA subsidiary. Each share will convert into the right to receive $73.00 in cash, and the board has recommended that shareholders approve the deal.
Merger consideration: $73.00 in cash per share of common stock, less any required tax withholdings
Buyer: Merck KGaA, Darmstadt, Germany, through its subsidiary EMD Holdings NewCo, Inc.
Closing requires majority shareholder approval, expiration of the Hart-Scott-Rodino waiting period and other required approvals, and no Burdensome Condition
onsemi agreed to acquire Synaptics in an all-stock transaction with a total enterprise value of approximately $7 billion. Each Synaptics share will convert into 1.350 onsemi shares, a premium of approximately 19% to the 10-day volume weighted average closing prices, and Synaptics stockholders are expected to own about 12% of the combined company. Closing is expected in mid-2027, subject to a Synaptics stockholder vote, regulatory approvals and other conditions, and Synaptics agreed to pay onsemi a $235 million termination fee in specified circumstances.
Each Synaptics share converts into 1.350 shares of onsemi common stock; the deal is all-stock
Total enterprise value of approximately $7 billion, about a 19% premium to 10-day VWAP
Expected close in mid-2027; the End Date is June 25, 2027, extendable up to 21 months
Synaptics termination fee of $235 million; onsemi regulatory termination fee of $320 million
onsemi agreed on June 25, 2026 to acquire Synaptics in an all-stock transaction with a total enterprise value of about $7 billion, using a fixed exchange ratio of 1.350 onsemi shares for each Synaptics share. Synaptics stockholders would own about 12% of the combined company, so onsemi holders would be diluted, while onsemi expects the deal to be accretive to non-GAAP EPS within 18 months of closing. Closing is expected in mid-2027, subject to a Synaptics stockholder vote and regulatory approvals, and both companies reiterated their prior financial outlooks.
Fixed exchange ratio of 1.350 onsemi shares per Synaptics share; Synaptics holders to own about 12% of the combined company on a pro forma basis.
Total enterprise value of about $7 billion, an approximately 19% premium to the 10-trading-day volume weighted average closing prices.
onsemi expects $200 million in annual synergies and non-GAAP EPS accretion within 18 months of closing.
Closing expected in mid-2027; the merger agreement can be terminated if not completed by June 25, 2027, subject to extensions.
HeartCore Enterprises agreed on June 22, 2026 to sell its entire 51% stake in Sigmaways, Inc. and $2.19 million in Sigmaways promissory notes to Semaphore Technologies, with the closing on the same day. The up-to-$650,000 price consists of a $1,000 cash payment at closing and an earn-out of up to $649,000 tied to Sigmaways' future gross revenue, and HeartCore also gave up a $350,000 SAFE note as part of a mutual release. The company says the sale removes a loss-making subsidiary with a shareholders' deficit of about $3.6 million (unaudited) as of March 31, 2026 from its consolidated results.
Sold 229,500 shares (51% ownership) of Sigmaways and $2.19 million in promissory notes to Semaphore Technologies; closed June 22, 2026.
Purchase price up to $650,000: $1,000 cash at closing plus an earn-out of up to $649,000.
Earn-out equals 10% of Sigmaways gross revenue above $5,500,000 over the 12 months after closing, payable within 10 days after that period.
Sigmaways had a shareholders' deficit of about $3.6 million (unaudited) as of March 31, 2026; HeartCore contributed a $350,000 SAFE note from Heart-Tech Health, Inc. in a mutual release.
GigCapital8 Corp. entered a non-binding letter of intent with Quantisimo Corp., a special purpose vehicle created by WISeKey and SEALSQ, for a business combination. Under the letter, Quantisimo's existing equityholders would own a majority of the combined public company, and the pre-money enterprise value of Quantisimo is approximately $575 million. The deal is not binding and depends on definitive agreements, due diligence, shareholder approval, and financing, so it may not be completed.
Pre-money enterprise value of Quantisimo: approximately $575 million, with a substantial rollover of equity expected from existing equityholders.
Quantisimo's existing equityholders would own a majority of the combined company, which would be listed on a national stock exchange.
The press release says the parties aim to reach $2 billion through up to five additional acquisitions and expect the transaction to close in the first quarter of 2027.
Completion requires definitive documentation, shareholder approval, financing arrangements, and regulatory review; the filing states no assurance can be given.
On June 24, 2026, Passage Bio agreed to merge with Remix Therapeutics in an all-stock deal, with the combined company to operate as Remix Therapeutics under the ticker RMTX. Passage shareholders are expected to own about 7% of the combined company, subject to adjustment based on Passage's net cash at closing, and will receive contingent value rights tied to milestones from its out-licensed pediatric gene therapy assets. Closing requires stockholder approvals and a concurrent Remix financing of at least $100 million, and is expected in the fourth quarter of 2026.
Remix has been ascribed an aggregate equity value of $226 million; Passage's equity value is expected to be about $20 million, subject to net cash adjustment.
Remix will complete a concurrent financing of at least $100 million immediately before the merger closes.
Termination payments: $17.5 million from Remix to Passage, or $1.548 million from Passage to Remix, in specified circumstances.
Peter Smith, Ph.D., Remix's co-founder and CEO, will become CEO of the combined company; the merger outside date is December 24, 2026.
Green Dot stockholders approved the merger with CommerceOne Financial and the separation agreement at a June 23, 2026 special meeting, with more than 99% of votes cast in favor of each. Under the proposed transaction, CommerceOne would acquire Green Dot Bank and Smith Ventures would acquire Green Dot's non-bank fintech operations, and completion is expected in the third quarter of 2026 subject to regulatory approvals.
Merger proposal: 40,869,891 votes for, 139,918 against, 52,234 abstentions; more than 99% of votes cast were in favor.
Separation proposal: 40,709,555 votes for, 300,237 against, 52,251 abstentions; more than 99% of votes cast were in favor.
Advisory vote on transaction-related executive compensation: 35,353,034 for, 4,957,445 against, 751,564 abstentions; not a condition to completion.
Quorum of 72.44% was reached with 41,062,043 of 56,682,705 shares present; completion is expected in Q3 2026 pending regulatory approvals from the Federal Reserve, Alabama State Banking Department and Utah Department of Financial Institutio
Boundless Bio agreed on June 22, 2026 to an all-stock merger with privately held Serapha Bio, a clinical-stage company developing an in vivo base editing therapy for Alpha-1 Antitrypsin Deficiency. Boundless stockholders are expected to own about 3.69% of the combined company, and the company's CEO, Zachary Hornby, steps down effective July 1, 2026, which affects shareholders' stake and the company's management.
Merger agreement dated June 22, 2026; the combined company is expected to operate as Serapha Bio and trade as AATD, subject to Nasdaq approval
Pre-merger Boundless holders expected to own about 3.69% and Serapha holders about 96.31% of the combined company, fully diluted
Boundless may pay a pre-closing cash dividend; the press release says about $44 to $48 million, and the press release states the BBI-940 program will not be advanced
CEO Zachary Hornby steps down July 1, 2026; Chief Legal Officer Jessica Oien to serve as principal executive officer; closing expected in Q4 2026
FMC Corporation signed a framework agreement on June 18, 2026, to sell underutilized buildings and land at its Stine Research Center campus in Newark, Delaware, to Ercor Elkton, LLC, for gross cash proceeds of approximately $114 million. FMC expects to use the proceeds to pay down debt and says research operations will continue at the site, but the agreement is preliminary and may not result in a completed transaction.
Gross cash proceeds of approximately $114 million from the sale to Ercor Elkton, LLC, subject to due diligence and other conditions and adjustments
Agreement dated June 18, 2026; closing is expected in the fourth quarter, and FMC plans to negotiate a leaseback for facilities it actively operates
FMC expects the proceeds to be used to pay down debt and says its Stine Research Center will continue to operate at the site
FMC retains ownership of the adjacent Maryland property; the filing states there can be no assurance the agreement will result in a transaction
Stellus Capital Investment Corp entered a new investment advisory agreement with Stellus Capital Management, LLC on June 22, 2026, the same day Ridgepost Capital, LLC completed its acquisition of the adviser. The filing states the new agreement's terms, including advisory fees and fee calculations, are identical to the prior agreement dated October 26, 2012, apart from its date and term.
Stockholders approved the New Advisory Agreement on June 16, 2026; the company entered into it on June 22, 2026.
The agreement took effect on June 22, 2026, upon the closing of Ridgepost Capital, LLC's acquisition of Stellus Capital Management, which changed control of the adviser.
The initial term is two years from June 22, 2026, then renews year to year if approved annually as required under the 1940 Act.
Ridgepost Capital, LLC's parent, Ridgepost Capital, Inc., is listed on the New York Stock Exchange.
Ridgepost Capital completed its acquisition of Stellus Capital Management, LLC on June 22, 2026, paying $125 million in cash, 11,191,149 Units and 579,096 Class A common shares at closing. The company drew $139 million on its revolving credit facility to fund the cash portion, leaving about $14 million available, and up to an additional $60 million may be paid as an earnout tied to Stellus's performance in 2027 and 2029, which could dilute existing shareholders if paid in equity.
Closing cash consideration of $125 million, subject to customary adjustments; closing equity of 11,191,149 Units and 579,096 Class A common shares
Up to $60 million additional earnout payable in 2028 and 2030, in Units or Class A shares, with up to 50% payable in cash at the sellers' option
Revolving credit facility drawn $139 million on June 18, 2026; commitments raised by $20 million to $195 million; about $14 million available as of June 22, 2026
Sellers' shares subject to lock-up, with one-third released on each of the first, second and third anniversaries of the closing
Booz Allen agreed on June 19, 2026 to buy Ultra I&C Mission Solutions, a defense technology business, from Ultra Electronics for $720 million, subject to adjustments and customary closing conditions. The filing says the deal is expected to close in the second quarter of fiscal 2027, and that the company believes its liquidity and financing options are sufficient to complete it.
Purchase price is $720 million, subject to certain adjustments, under a stock purchase agreement dated June 19, 2026
Closing expected in the second quarter of fiscal 2027, which ends September 30, 2026; either party may terminate if not closed by December 19, 2026
Booz Allen expects the acquired business's revenue to grow at a strong double-digit rate for several years, with EBITDA margins well above 20%
Arcosa agreed on June 21, 2026 to merge with a subsidiary of CRH Americas, with Arcosa surviving as a wholly owned CRH subsidiary. Each Arcosa common share would convert into $150.00 in cash, and the deal needs approval from a majority of Arcosa stockholders and regulatory clearances, with closing expected in Q1 2027. Shareholders would receive cash rather than continued ownership of Arcosa stock, and the 8-K sets out termination fees payable in both directions.
Merger consideration of $150.00 per share in cash, per the merger agreement; CRH's press release says the offer implies a 25% premium to Arcosa's 60-day trading VWAP as of June 18, 2026
Termination fee of $371,967,952 payable by CRH Americas in certain regulatory-failure cases, and $260,377,567 payable by Arcosa in certain cases including a superior proposal or change of board recommendation
Outside Date of June 21, 2027, extendable by up to six months if only antitrust or regulatory conditions remain unsatisfied
CRH press release says closing is expected in Q1 2027 and the deal is funded with available cash and committed debt financing
AbbVie agreed to acquire Apogee Therapeutics for $135.11 per share in cash, a total equity value of about $10.9 billion, according to a June 22, 2026 joint press release. The deal is expected to close in the third quarter of 2026, subject to Apogee shareholder approval and regulatory approvals, and AbbVie expects it to be accretive to adjusted diluted earnings per share beginning in 2032.
Price: $135.11 per Apogee share in cash; total equity value of about $10.9 billion
Expected closing: third quarter of 2026, subject to Apogee shareholder approval and regulatory approvals
Accretion to AbbVie adjusted diluted EPS expected beginning in 2032
Fairmount Funds Management LLC and Venrock Associates have signed voting agreements supporting the deal
CRH agreed on June 21, 2026 to acquire Arcosa, Inc. through a merger in which Arcosa becomes a wholly owned subsidiary, with Arcosa stockholders to receive $150.00 in cash per share. The deal is expected to close in Q1 2027, subject to Arcosa stockholder approval, regulatory approvals and customary conditions, and CRH plans to fund it with available cash and committed debt financing.
Price of $150.00 per share in cash, a 25% premium to Arcosa's 60-day trading VWAP as of June 18, 2026; enterprise value of approximately $8.5 billion
Termination fee of $371,967,952 payable by Parent in certain regulatory-failure circumstances; $260,377,567 payable by Arcosa in certain circumstances
Outside Date of June 21, 2027, extendable by up to six months if only antitrust or regulatory conditions remain unsatisfied
CRH expects $175 million of run-rate cost synergies by year three and pro forma FY 2026E net debt to Adjusted EBITDA of 2.4x
Chicago Atlantic Real Estate Finance (REFI) signed a merger agreement on June 17, 2026, under which it will elect to be regulated as a business development company and merge into Chicago Atlantic BDC (LIEN), with LIEN as the surviving public company. REFI stockholders would receive LIEN shares based on the ratio of each company's adjusted net asset value per share, and would be expected to own about 50.5% of the combined company based on March 31, 2026 figures, subject to the final ratio at closing.
Exchange is based on adjusted NAV per share at closing; REFI holders would be expected to own about 50.5% of LIEN based on March 31, 2026 NAVs.
REFI's current management agreement with its manager terminates automatically at the BDC election, without termination payment.
Closing is expected in the fourth quarter of 2026, subject to stockholder approvals at both companies and regulatory approvals.
Chicago Atlantic agreed to fund $2.0 million of REFI's transaction-related expenses at or immediately before closing.
Deluxe agreed on June 17, 2026 to acquire Celero Commerce, a payment processor for small to mid-sized businesses, for approximately $625 million in cash plus seller expenses and adjustments. The deal is funded with an incremental $375 million Term Loan A and drawings on Deluxe's existing revolving credit facility, and Deluxe expects net leverage of about 3.9x at closing. Deluxe reaffirmed its 2026 full-year guidance, which excludes Celero, and plans to update guidance after closing.
Purchase price of approximately $625 million in cash, funded by a $375 million incremental Term Loan A and the existing revolver
Deluxe expects net leverage of about 3.9x at closing and a return to below 3.0x within 24 months after closing
Celero reported over $200 million in 2025 revenue and a 28% adjusted EBITDA margin, per the company; Deluxe expects over $15 million in cost synergies by 2028
Closing is subject to regulatory approvals and customary conditions, with completion expected in the third quarter of 2026
Chicago Atlantic BDC (LIEN) signed a merger agreement under which REFI will elect to be regulated as a business development company and merge into LIEN in an all-stock deal, with LIEN continuing as the surviving public company. REFI stockholders would be expected to own about 50.5% of LIEN after closing, based on March 31, 2026 net asset values, and the final split depends on the NAV ratio calculated shortly before closing. Completion requires stockholder approvals at both companies, regulatory approvals and lender consents, with closing expected in the fourth quarter of 2026.
Former REFI stockholders would be expected to own approximately 50.5% of LIEN after the merger, based on March 31, 2026 NAVs; the final percentage depends on the closing NAV ratio.
Pro-forma NAV of $613 million and pro-forma portfolio of $771 million in investments, based on March 31, 2026 financial statements as reported on Form 10-Q.
LIEN board will consider in good faith a stock repurchase program of up to $25.0 million after closing, subject to market conditions.
Merger is currently expected to close in the fourth quarter of 2026; Chicago Atlantic has agreed to fund $2.0 million of REFI's transaction-related expenses.
Ziff Davis closed its sale of the Connectivity division to Accenture on June 17, 2026, for an aggregate purchase price of $1.2 billion in cash, subject to customary adjustments. Before closing, the company obtained lender consent under its credit agreement and designated the division's subsidiaries as unrestricted under its 4.625% Senior Notes indenture. The filing does not report the division's financial results or the company's gain or loss on the sale.
Sale of Connectivity division to Accenture Inc. closed June 17, 2026, for $1.2 billion in cash
Consent Agreement with lenders dated June 15, 2026, permits the sale under the existing credit agreement
Division subsidiaries designated unrestricted under the indenture for the 4.625% Senior Notes due 2030 shortly before closing
Pro forma financial information to be filed by amendment within four business days of closing
Harmonic Inc. completed the sale of its Video Business to Leone Media Inc. (d/b/a MediaKind) on June 16, 2026, for $145 million in cash, subject to customary post-closing adjustments. The company says it will now focus its resources on its broadband business, and the press release describes the proceeds as a significant capital infusion to the balance sheet.
Sale closed June 16, 2026; purchase price of $145 million in cash, subject to adjustments for net working capital, cash and indebtedness, and specified selling expenses
Harmonic agreed not to compete with the Video Business for three years after closing; both parties agreed to indemnify each other for certain losses under the agreement
Neven Haltmayer, Senior Vice President and General Manager, Video Business, resigned effective June 16, 2026, after 20 years of service
Harmonic plans an Investor Day in New York City on September 15, 2026
On June 16, 2026, Yum Brands agreed to sell its global Pizza Hut business, excluding China, to Toppings TopCo, LLC for $1.488 billion in cash, plus up to $75 million in contingent earn-out payments tied to 2027 through 2029 performance. The same day, it agreed to sell its Pizza Hut business in the People's Republic of China to Yum China Holdings for $1.2 billion in cash. Both deals are subject to closing conditions, and the filing does not state the effect on the company's earnings.
Global Pizza Hut sale: $1.488 billion in cash, subject to adjustments, plus a possible $75 million earn-out based on fiscal years 2027, 2028 and 2029 targets.
China Pizza Hut sale: $1.2 billion in cash to Yum China Holdings, with closing no earlier than August 17, 2026 unless Yum China sets an earlier date.
Global sale closing requires the HSR waiting period to expire, other antitrust approvals and completion of reorganization steps; either party may terminate if closing has not occurred by September 16, 2026.
The company will provide post-closing indemnification for retained liabilities, and the buyer receives a five-year non-competition covenant.
Space Exploration Technologies Corp. signed a merger agreement on June 16, 2026, to acquire Anysphere, Inc. (Cursor) in a deal based on an implied equity value of $60.0 billion. Cursor holders would receive Class A common stock, with the share count set by the seven-day volume-weighted average price before closing, and the company expects the deal to close in the third quarter of 2026, subject to closing conditions including regulatory approvals.
Merger Sub X67 Inc. will merge into Cursor, which will survive as a wholly owned subsidiary of the company
Implied equity value of Cursor is $60.0 billion
Consideration is Class A common stock priced on the seven-day VWAP before closing
Expected closing in the third quarter of 2026, subject to regulatory approvals
Prestige Consumer Healthcare completed its $1.045 billion cash purchase of the Breathe Right brand and certain other brands on June 12, 2026, funded by a new term loan and cash on hand. The company also amended its asset-based revolving credit line, raising commitments to $225 million and extending its maturity five years from the closing date, and the filing describes Breathe Right as becoming Prestige's largest brand.
Purchase price of $1.045 billion in cash for Breathe Right and certain other brands from Foundation Consumer Brands, LLC, closed June 12, 2026
New term loan of $1.045 billion priced at Term SOFR plus 2.00%, with quarterly amortization of 0.25% and a possible second draw of up to $95.0 million to help fund the LaCorium Acquisition
ABL revolving line commitments increased to $225 million, with maturity extended five years from the closing date
NextEra Energy filed unaudited pro forma financial statements for its proposed merger with Dominion Energy, which was agreed on May 15, 2026. The filing estimates total merger consideration of $62.4 billion, based on NEE's $84.84 closing price on June 11, 2026, and shows pro forma earnings per share below NEE's historical figures, though pro forma net income is higher. The deal still needs shareholder approvals and several regulatory approvals before closing.
Each Dominion Energy share would receive 0.8138 NEE shares plus a pro rata share of $360 million in cash.
Pro forma basic EPS for the three months ended March 31, 2026 was $0.92, versus NEE's historical $1.05.
Pro forma basic EPS for 2025 was $3.20, versus NEE's historical $3.31; pro forma 2025 operating revenues were $42.9 billion.
Closing requires approval by both companies' shareholders and approvals including HSR, FERC, NRC, and the Virginia, North Carolina and South Carolina regulators.
Fox Corporation signed a merger agreement on June 14, 2026, to acquire Roku, Inc. Roku holders would receive $96.00 in cash and 0.9693 of a FOX Class A share for each share, and Fox has a $12 billion bridge loan commitment to help fund the deal. The deal requires Roku and Fox stockholder approvals, antitrust clearance, and a Nasdaq listing approval, and it could cause Fox to issue new shares and take on new debt.
Merger Agreement dated June 14, 2026, under which Roku becomes a wholly owned subsidiary of Fox
Each Roku share converts into $96.00 in cash plus 0.9693 of a FOX Class A share, with the exchange ratio adjusted if dissenting shares are involved
Fox must pay a $1,237,262,000 regulatory termination fee in certain antitrust-related terminations, and a $866,084,000 termination fee in other specified cases
Morgan Stanley Senior Funding, Inc. committed a $12 billion 364-day senior unsecured bridge term loan; Roku founder and CEO Anthony Wood and related holders represent about 55% of Roku voting power under a voting agreement
Talen Energy completed its acquisition of the Lawrenceburg Power Plant in Indiana and the Waterford Energy Center and Darby Generating Station in Ohio from Energy Capital Partners on June 15, 2026. The purchase price combined about $2.55 billion in cash, subject to post-closing adjustments, with 2,399,998 new shares of Talen common stock, and the company amended its credit facilities to support the deal.
Cash consideration of approximately $2.55 billion, subject to customary adjustments, funded partly by 6.125% notes due 2031 and 6.375% notes due 2033 issued in April 2026
Stock consideration of 2,399,998 shares of common stock issued to the sellers, subject to a 90-day lock-up on 50% of the shares and a 180-day lock-up on the rest
Revolving credit facility increased from $900 million to $1.35 billion, and stand-alone letter of credit facility upsized from $1.1 billion to $1.5 billion, with maturity extended to December 2029
Talen states the acquisition is immediately accretive, adding over 15% to cash flow per share; the filing does not provide a supporting calculation
Tripadvisor entered into a put option agreement on June 14, 2026, under which American Express Travel Related Services has irrevocably committed to buy TheFork, its European restaurant reservation platform, for $700 million in cash, subject to adjustments. The equity purchase agreement cannot be signed until the French Works Council consultation is complete, and closing is expected by the end of 2026 after regulatory approvals. The company said potential uses of the proceeds include share repurchases, debt paydown, or inorganic investment in its Experiences category.
Buyer is American Express Travel Related Services Company, Inc.; the put option agreement is dated June 14, 2026
Purchase price is $700 million, all cash, subject to certain adjustments, to be paid from the buyer's cash on hand
TheFork's last twelve-month revenue was $232 million and segment adjusted EBITDA was $28 million as of Q1 2026
Transaction is expected to close before the end of 2026, subject to regulatory approvals and customary conditions
Payoneer Global agreed on June 12, 2026 to be acquired by Nuvei in an all-cash merger valued at about $2.75 billion in equity. Payoneer stockholders would receive $7.40 per share, and the deal requires stockholder approval, regulatory clearances and other customary conditions before closing, which the companies expect in mid-2027.
Merger consideration is $7.40 per share in cash, representing a total equity value of approximately $2.75 billion
Payoneer would owe Nuvei a $89 million termination fee in certain circumstances, while Nuvei would owe Payoneer $165 million if it fails to close when required
Closing requires approval by a majority of Payoneer's outstanding common stock and clearance under the Hart-Scott-Rodino Act and other approvals; the agreement can be terminated if the merger is not completed by June 12, 2027, subject to a
Payoneer's board has unanimously approved the merger and recommends that stockholders adopt the agreement
Roku entered a merger agreement under which Fox Corporation will acquire Roku in a cash-and-stock deal valued at $160.00 per Roku share, or about $22 billion in enterprise value. Roku stockholders would receive $96.00 in cash and 0.9693 Fox Class A shares per share, and Roku's Class A stock would be delisted from Nasdaq if the deal closes, which is expected in the first half of calendar 2027.
Consideration: $96.00 in cash plus 0.9693 Fox Class A shares per Roku share, with the stock portion based on a $66.03 reference price as of June 10, 2026
Roku stockholders are expected to own about 27% of the combined company
Closing is subject to Roku and Fox shareholder approvals and U.S. and certain non-U.S. regulatory approvals; a Roku holder group controlling at least a majority of voting power has agreed to vote in favor
Fox has obtained $12.0 billion of committed bridge financing from Morgan Stanley Senior Funding
Titan Acquisition Corp. signed a first amendment on June 11, 2026 to its June 1, 2026 business combination agreement with OpenPayd Holdings Limited. The amendment clarifies that the parties will use reasonable best efforts to redeem all outstanding Purchaser Warrants before or at the acquisition closing. The filing does not disclose valuation, deal terms beyond this clarification, or a closing date.
Business combination agreement with OpenPayd Holdings Limited dated June 1, 2026
First Amendment executed June 11, 2026
Parties to use reasonable best efforts to redeem all outstanding Purchaser Warrants prior to or concurrent with the Acquisition Closing
Velos Acquisition I Corp. (formerly M3-Brigade Acquisition V Corp.) and ReserveOne mutually terminated their July 2025 business combination agreement effective June 12, 2026, and the related subscription agreements ended. The company is pursuing a substitute arrangement that includes a sponsor share sale, shareholder votes on extending its deadline and renaming the company, and non-redemption commitments, leaving shareholders without the ReserveOne transaction.
Business Combination Agreement with ReserveOne terminated effective June 12, 2026; related subscription agreements terminated
Investors agreed to buy 4,279,279 Class A shares at $3.33 per share, with $14,250,000 in gross proceeds to the sponsor, subject to closing
Proposed amendments would extend the business combination deadline from August 2, 2026 to August 2, 2027 and change the company name to Velos Acquisition I Corp.
Voting and non-redemption agreements cover up to 16,000,000 Class A shares; sponsor may transfer up to 8 million private placement warrants
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.